Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "IPA"

1612 News Found

Bisleri expands CSR support for rural mental health programme in MP
Healthcare | April 15, 2026

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district


WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat
Public Health | April 14, 2026

WHO unites 800+ institutions in historic global health push to prepare for next pandemic threat

Scientists at the forum warned of an increasingly volatile health landscape


Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study
News | April 14, 2026

Thermo Fisher and Singapore’s PRECISE launch major proteomics push in 100,000-person study

The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation


GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen
News | April 14, 2026

GoodRx partners with Eli Lilly to expand access to new oral GLP-1 Foundayo & Zepbound KwikPen

GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access


Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend
Hospitals | April 14, 2026

Kauvery Hospital conducts 4th edition of ECG Masterclass 2026; 400+ medical professionals attend

Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”


India Pharma 2026 showcases sectoral transformation through four key plenary discussions
Policy | April 14, 2026

India Pharma 2026 showcases sectoral transformation through four key plenary discussions

Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals


CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi
Drug Approval | April 14, 2026

CDSCO reforms cut trial approval timelines by over 50%: DCGI Dr Rajeev Raghuvanshi

Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews


Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector
Biopharma | April 14, 2026

Gennova CEO Dr Sanjay Singh sees strong innovation momentum for India’s biopharma sector

Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics